A review of anabolic therapies for osteoporosis
AUTOR(ES)
Lane, Nancy E
FONTE
BioMed Central
RESUMO
Osteoporosis results from a loss of bone mass and bone structure such that the bone becomes weak and fractures with very little trauma. Until recently, the approved osteoporosis therapies prevented more bone loss by altering osteoclast activity and lifespan. Recently, attention has turned away from osteoclast inhibition to agents that can stimulate the osteoblast to form new bone, or anabolic agents. This article reviews both approved and experimental anabolic agents that improve bone mass by improving osteoblast activity, or increasing osteoblast number. The use of the anabolic agents to improve bone mass and strength followed by agents that prevent the new bone mass from being lost may offer the ability to cure osteoporosis and reduce bone fracture healing time.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=193734Documentos Relacionados
- Anabolic therapy for osteoporosis: update on efficacy and safety
- Non-pharmacological therapies for postpartum analgesia: a systematic review
- Short- and long-term effects of estrogen and synthetic anabolic hormone in postmenopausal osteoporosis
- Editorial Comment: Novel Treatment for Premature Ejaculation in the Light of Currently Used Therapies: A Review
- Translational Mini-Review Series on B Cell-Directed Therapies: Recent advances in B cell-directed biological therapies for autoimmune disorders